Eurofins Scientific earnings calendar, shares on Paris Euronext radar

Eurofins Scientific heads toward its next earnings update with analysts watching margins and growth in testing services, while the shares trade steadily on Euronext Paris.

By Mark Bergmann, Earnings & Calendar desk. Reviewed prior to publication on 2026-06-25, 20:04.

Eurofins Scientific SE (FR0014000MR3) stands out on Euronext Paris as investors look ahead to the next quarterly earnings release and updated guidance. Consensus expectations for revenue growth and margins frame the coming report, according to analyst compilations on MarketScreener.

What analyst consensus shows

Eurofins is covered by a group of European brokerages following its role as a major testing services provider, with several houses including UBS and Deutsche Bank publishing regular research updates on the stock. On MarketScreener, the majority of analysts rate the shares at Hold or Buy, and the compiled consensus points to moderate top-line growth over the next 12 to 18 months.

Typical models track revenue contributions from food, environmental, pharmaceutical and clinical diagnostics testing, and embed assumptions for mid-single-digit organic growth and incremental margin improvements. According to recent consensus data, analysts expect Eurofins to continue benefiting from structural demand for outsourced laboratory services across Europe and North America.

Upcoming earnings and calendar

The Eurofins investor relations site lists a regular cadence of quarterly publications, including half-year and full-year reports with detailed segment data and cash flow information. Earnings releases are typically accompanied by conference calls or webcasts where management reviews performance in core testing segments and comments on trends in volumes and pricing.

For the coming reporting period, markets will focus on how Eurofins manages cost inflation, particularly in energy, consumables and staffing, and whether the group can sustain margin resilience in its network of laboratories. Investors will also watch for updates on acquisition activity, as Eurofins historically expanded via targeted deals in specialized testing niches.

How Eurofins earns its money

Eurofins generates most of its revenue by providing laboratory testing services in food safety, pharmaceuticals, environmental monitoring and clinical diagnostics. Customers range from global food producers to drug makers and hospitals, who outsource analytical work to Eurofins laboratories in Europe, North America and Asia.

Where Eurofins shares trade today

Eurofins Scientific SE (FR0014000MR3) shares trade on 2026-06-25, 18:00 on Euronext Paris at 68.04 euros, based on recent data compiled by MarketScreener.

Eurofins Scientific key share data

• Company: Eurofins Scientific SE
• ISIN: FR0014000MR3
• WKN: A3DPE3
• Ticker: ERF
• Trading venue: Euronext Paris
• Price (as of 2026-06-25, 18:00): 68.04 euros
• Market cap: approximately 13.0 billion euros (as of 2026-06-25)
• Sector / industry: Health Care - Life Sciences Tools & Services
• Index membership: CAC All-Share
• Next earnings date: not officially scheduled

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security.